VistaGen Therapeutics
VTGN
VTGN
51 hedge funds and large institutions have $30.3M invested in VistaGen Therapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.11% less ownership
Funds ownership: 55.24% → 53.13% (-2.1%)
22% less capital invested
Capital invested by funds: $39M → $30.3M (-$8.75M)
Holders
51
Holding in Top 10
–
Calls
$437K
Puts
$73K
Top Buyers
| 1 | +$216K | |
| 2 | +$115K | |
| 3 | +$106K | |
| 4 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$99.9K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$78.7K |
Top Sellers
| 1 | -$778K | |
| 2 | -$456K | |
| 3 | -$368K | |
| 4 |
Morgan Stanley
New York
|
-$88.9K |
| 5 |
PAP
Persistent Asset Partners
Hong Kong
|
-$79.1K |